Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study
Author(s):
Pagani, M.; De Carli, F.; Morbelli, S.; Öberg, J.; Chincarini, A.; Frisoni, G.B.; Galluzzi, S.; Perneczky, R.; Drzezga, A.; van Berckel, B.N.M.; Ossenkoppele, R.; Didic, M.; Guedj, E.; Brugnolo, A.; Picco, A.; Arnaldi, D.; Ferrara, M.; Buschiazzo, A.; Sambuceti, G.; Nobili, F.